No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck

British Journal of Cancer

Volumn 82, Issue 4, 2000, Pages 757-759

  Hamel, N ^a   Black, M J ^b   Ghadirian, P ^d   Foulkes, W D ^a,c  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Head and cancer; HPV; Low penetrance; P53; Polymorphism; Squamous cell

Indexed keywords

ARGININE; PROTEIN P53;

ARTICLE; CANCER RISK; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TOBACCO; UTERINE CERVIX CANCER; WART VIRUS;

EID: 0033961883     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0993     Document Type: Article

References (12)

1. Buchan I (1998) Arcus QuickStat (biomedical) Version 1.2. Addison Wesley Longman: Cambridge
2. Franceschi S, Munoz N, Bosc XF, Snijders PJ and Walboomers JM (1996) Human papillomavirus and cancer of the upper aerodigestive tract: a review of epidemiological and experimental evidence. Cancer Epidemiol Biomarkers Prevent 5: 567-575
3. Helland Å, Langerød A, Hilde J, Olsen AO, Skovlund E and Børresen-Dale A-L (1998) P53 polymorphism and risk of cervical cancer. Nature 396: 530-531
4. Hildesheim A, Schiffman M, Brinton LA, Fraumeni JF Jr, Herrero R, Bratti MC, Scharetz P, Mortel R, Barnes W, Greenberg M, McGowan L, Scott DR, Martin M, Herrera JE and Carrington M (1998) P53 polymorphism and risk of cervical cancer. Nature 396: 531-532
5. Josefsson AM, Magnusson PKE, Ylitalo N, Quarforth-Tubbin P, Pontén J, Adami HO and Gyllensten UB (1998) P53 polymorphism and risk of cervical cancer. Nature 396: 531
6. McKaig RG, Baric RS and Olshan AF (1998) Human papillomavirus and head and neck cancer: epidemiology and molecular biology. Head Neck 20: 250-265
7. Minaguchi T, Kanamori Y, Matsushima M, Yoshikawa H, Taketani Y and Nakamura Y (1998) No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res 58: 4585-4586
8. Portugal LG, Goldengerg JD, Wenig BL, Ferrer KT, Nodzenski E, Sabnani JB, Javier C, Weichselbaum RR and Vokes EE (1997) Human papillomavirus expression and p53 gene mutation in squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 123: 1230-1234
9. Rosenthal AN, Ryan A, Al-Jehani RM, Storey A, Harwood CA and Jacobs IJ (1998) P53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet 352: 871-872
10. Schwartz SM, Daling JR, Doody DR, Wipf GC, Carter JJ, Madeleine MM, Mao EJ, Fitzgibbons ED, Huang S, Beckmann AM, McDougall JK and Galloway DA (1998) Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst 90: 1626-1636
11. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G and Banks L (1998) Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer. Nature 393: 229-234
12. zur Hausen H (1996) Papillomavirus infections - a major cause of human cancers. Biochem Biophys Acta 1288: F55-F78